• ML133 HCl: A Causal Map for Kir2.1 Research

  2026-09-29

  ML133 HCl is a selective potassium channel inhibitor that helps separate Kir2.1-dependent signaling from downstream vascular remodeling effects. This article translates published pulmonary vascular findings into practical assay-design, interpretation, and validation decisions.

• D-Lin-MC3-DMA: LNP Workflow and QC Guide

  2026-09-29

  D-Lin-MC3-DMA provides an ionizable cationic liposome component for research workflows involving siRNA and mRNA lipid nanoparticles. This guide covers solvent handling, formulation setup, quality control, and failure analysis, while emphasizing that product-dossier benchmarks should not be treated as a validated protocol for every cargo, species, or administration route.

• GKT137831 for Redox and Ferroptosis Research

  2026-09-28

  GKT137831 is a dual NADPH oxidase Nox1/Nox4 inhibitor for connecting ROS biology with vascular remodeling, fibrosis, and membrane-injury assays. This practical guide outlines concentration selection, hypoxia workflows, ferroptosis-oriented readouts, and troubleshooting strategies without overstating an unproven direct link to TMEM16F.

• Amiloride (MK-870): Designing Interpretable Assays

  2026-09-28

  Amiloride (MK-870) can probe epithelial sodium transport, PC2-associated activity, and uPAR-linked processes—but a response alone does not identify its cause. This guide presents a target-aware assay framework and draws a carefully bounded lesson from clinical trial design in WHIM syndrome.

• TSPAN18–STIM1 Signaling in Prostate Bone Metastasis

  2026-09-27

  Zhou et al. identify TSPAN18 as a regulator that protects STIM1 from TRIM32-mediated ubiquitination, sustaining calcium entry and promoting prostate cancer migration, invasion, and bone metastasis. The findings connect protein stability with calcium signaling and suggest a potential target for further study, while leaving important questions about therapeutic translation unresolved.

• How Kinase Inhibitors Accelerate p38α Dephosphorylation

  2026-09-26

  The reference study shows that selected p38α inhibitors can do more than block kinase activity: by stabilizing an activation-loop conformation, they make a phosphothreonine more accessible to the phosphatase WIP1 and accelerate its removal. Biochemical experiments and X-ray structures support this conformation-directed mechanism, while leaving open how broadly it applies beyond the tested inhibitors and experimental system.

• Vemurafenib (PLX4032) for Melanoma Resistance

  2026-09-25

  Use Vemurafenib as a BRAF-targeted perturbation to measure melanoma cell proliferation inhibition and expose adaptive signaling—not simply as a single end-point viability reagent. Pair dose and time courses with an ARID1A-loss model and orthogonal pathway readouts to distinguish initial MAPK suppression from resistance-associated rewiring.

• Fiber Density Shapes Annulus Fibrosus Collagen Phenotypes

  2026-09-25

  The study identifies electrospun fiber density as a tunable cue associated with distinct collagen-producing phenotypes in annulus fibrosus cells. Its findings connect low- and high-density scaffolds with different mechanotransduction signatures and offer a design rationale for spatially organized repair materials, while leaving important questions about native-disc performance unresolved.

• FerroOrange for Live-Cell Fe²⁺ Assays

  2026-09-24

  FerroOrange provides a live-cell readout of intracellular Fe²⁺ that can complement ferroptosis markers and mitochondrial analyses in macrophage studies. This practical guide connects the PM2.5–Fra2/LCN2 asthma findings to an optimized imaging or flow-cytometry workflow, while clarifying what the probe can—and cannot—tell you.

• Netrin-1 Impairs Adipogenesis in Obesity

  2026-09-24

  This study identifies adipose-derived Netrin-1 as a brake on adipocyte differentiation, linking its effects to reduced PPARγ activity and increased Wnt/β-catenin signaling. In mice, loss and overexpression experiments associate Netrin-1 with adipose remodeling and glucose regulation, suggesting that the capacity to form new adipocytes may matter as much as total fat mass.

• BHQ: SERCA Inhibition in Calcium Signaling Research

  2026-09-23

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a SERCA inhibitor used to investigate intracellular calcium storage and calcium homeostasis disruption. A 2025 mouse study reports that BHQ increased hematopoietic stem cell mobilization through a SERCA–CaMKII–STAT3–CXCR4 pathway, but it does not establish a human treatment effect.

• Amiloride (MK-870): Reliable Cell Assays

  2026-09-23

  A scenario-driven guide to using Amiloride (MK-870), SKU BA2768, in cell viability, proliferation, cytotoxicity, ion-transport, and endocytosis experiments. It connects product handling requirements with published evidence and practical controls for interpreting assay-specific effects.

• Trilaurin: Practical Protocols for Lipid Workflows

  2026-09-22

  Trilaurin, also called Glycerol Tridodecanoate, provides a defined C12 triacylglycerol for lipid formulation, enzymatic synthesis, and selected biomedical workflows. It should be used as a lipid-phase component or biocatalytic synthesis substrate after compatibility testing, not as a water-soluble reagent or stand-alone evidence of oral or anticancer efficacy.

• Streptavidin-HyperFluor 647 in Assay Design

  2026-09-22

  Explore how Streptavidin-HyperFluor 647 supports low-background biotin detection across imaging, flow cytometry, and FRET workflows. This guide also contrasts mature streptavidin readouts with the biotin-free, click-compatible BmTyr strategy reported for primary T-cell proteomics.

• GSK J4 HCl: An Assay-Design Guide

  2026-09-21

  GSK J4 HCl is a cell-permeable JMJD3 inhibitor that connects H3K27 demethylation with inflammatory gene control. This guide translates decidual CXCL10 findings into practical assay decisions while distinguishing biochemical potency, intracellular activity, and locus-specific chromatin effects.

554 records 3/37 page Previous Next 12345 下5页 Last page